CLICK ON THE HOTSPOTS TO DISCOVER MORE
Industry Talk
Pioglitazone: The insulin Sensitizing, Cost-Effective Cardioprotective Drug for Type 2 Diabetes
SPEAKER: Prof. Ralph DeFronzo (USA)
Professor of Medicine, Chief of the Diabetes Division
University of Texas Health Science Center & Deputy Director, Texas Diabetes Institute
San Antonio, Texas, United States of America
Videos
Actosmet
Incresync